AngioDynamics ANGO Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $292.5M-3.8% | $303.91M-10.3% | $338.75M+7.1% | $316.22M+8.7% | ||
| $134.79M-9.7% | $149.22M-9.3% | $164.51M+9.3% | $150.49M+12.1% | ||
| $157.71M+1.9% | $154.7M-11.2% | $174.25M+5.1% | $165.73M+5.7% | ||
| 53.9%+3.0pp | 50.9%-0.5pp | 51.4%-1.0pp | 52.4%-1.5pp | ||
| $26.22M-16.8% | $31.51M+5.5% | $29.88M-2.8% | $30.74M-15.5% | ||
| $103.14M+0.3% | $102.82M-1.4% | $104.25M+9.4% | $95.3M+17.2% | ||
| $42.09M+2.3% | $41.16M+2.9% | $40M+4.0% | $38.45M+7.1% | ||
| $197.66M-50.8% | $401.63M+78.2% | $225.43M+16.1% | $194.2M+1.1% | ||
| -$39.95M+79.2% | -$192.44M-276% | -$51.18M-79.8% | -$28.47M+19.3% | ||
| -13.7%+49.7pp | -63.3%-48.2pp | -15.1%-6.1pp | -9%+3.1pp | ||
| $978K+161% | -$1.61M-160% | $2.7M+293% | $688K-20.1% | ||
| —— | -$817K— | —— | —— | ||
| -$34.03M+82.2% | -$191.64M-252% | -$54.44M-81.8% | -$29.95M+16.9% | ||
| -$39K+99.5% | -$7.29M-265% | -$2M+41.4% | -$3.4M+24.5% | ||
| -$33.99M+81.6% | -$184.35M-252% | -$52.44M-57.6% | -$33.29M-5.5% | ||
| -11.6%+49.0pp | -60.7%-45.2pp | -15.5%-5.0pp | -10.5%+0.3pp | ||
| -$0.83+81.8% | -$4.57-246% | -$1.32-94.1% | -$0.68+16.0% | ||
| -$14.15M+91.4% | -$164.72M-711% | -$20.31M-2,413% | $878K+109% | ||
| -4.8%+49.4pp | -54.2%-48.2pp | -6%-6.3pp | 0.3%+3.5pp | ||
| -$39.95M+79.2% | -$192.44M-276% | -$51.18M-79.8% | -$28.47M+19.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is AngioDynamics's revenue?
- AngioDynamics (ANGO) generated $313.7M in revenue over the trailing twelve months, up 10.7% year over year.
- Is AngioDynamics profitable?
- AngioDynamics is not currently profitable: it reported a net loss of $31.4M over the trailing twelve months, a -10.0% net margin.
- What are AngioDynamics's profit margins?
- Gross margin is 54.3% and operating margin is -11.3%, with a -10.0% net margin.
- What is AngioDynamics's earnings per share?
- AngioDynamics's diluted EPS over the trailing twelve months is $-0.75.
- Where does AngioDynamics's income statement data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
